About Immucura
Immucura: a Vision of cell-based Immunotherapy comes to Fruition
It all started when in 2014 the father of Immucura’s CEO Johannes Schumacher developed cancer… Unfortunately, traditional methods were not able to offer a solution, that’s why Mr. Schumacher started investigating alternative therapies until he discovered a promising approach called DCT, Dendritic Cell Therapy.
This innovative method was not well-known to the public at that time, even though Dendritic Cells were first observed 153 years ago. But only in 1973 Dendritic Cells were correctly identified, when their ability to instruct the body’s immune system was revealed.
When Johannes learned about DCT, the first seed for the birth of Immucura was planted: the mission to provide cancer sufferers with alternative, non-invasive, and scientifically advanced cancer therapies was taking shape.
In 2015 Immucura started the cooperation with a lab located in Germany, while the first Immucura employee was hired in 2016. The following year, 4 more employees were taken on, and an office was rented in Calahonda, close to Marbella.
Since then, the company has undergone massive growth, leading to the foundation of new business units and the creation of the Vitalio group, incorporating all these realities.
With the increase of team members, a new office was sourced and inaugurated in 2022. Thanks to the company’s remarkable growth, already in 2023 the new workplace was getting tight and more business spaces were rented.
All departments experienced an unparalleled extension, leading to an increase of quality, service and mobility. Suddenly, patients from all over Europe could be reached and served, by the highly advanced logistic and administrative layout.
Today, the website is available in 9 languages and multilingual experts in the medical field are ready to assist patients from every corner of the globe.
The team was completed with highly skilled nutritionists, therapists and other professionals. At the heart of Immucura is a team of 12 doctors, each bringing years of holistic treatment experience.
The flourishing creation of new collaborations enabled Immucura to have access to some of the most advanced methods available on the market, like those provided by the lab located in Malaga, with whom Immucura started collaborating in 2022.
Thus, the dynamic evolution and global expansion of the corporation are ceaseless, showcased by the opening of branch offices and the continuous launch of new collaborations.
The unique concept offered by Immucura has revolutionized the world of Immunotherapy, especially for cancer patients.
In the rapidly evolving health landscape, Immucura has distinguished itself as a paragon of innovation and efficiency, with a unique blend of groundbreaking research, cutting-edge technology, and an unparalleled commitment to patient satisfaction.
Johannes Schumacher founds the company Immucura Med SL with the scope to provide non-invasive and advanced cancer therapies.
Due to the travel restrictions during the Covid-19 emergency, Immucura started sending out their medical staff to the patients' home, enabling the administration of DCT.
Thanks to the massive growth of the company, a new expansion is achieved and the company Immucura Limited is created.
Because the staff keeps increasing rapidly, a new office is sourced and the team moves to the center of Marbella in August 2022.
Subsidiary offices are opened in Morocco, while the head office is expanded with the arrival of new multilingual staff members.
The holding Vitalio AG is created, it incorporates Immucura, the new Immucura Diagnostics Center and other companies belonging to the rapidly expanding enterprise.
Mission Statement
– Immucura revolutionises cancer cure. Personalised, and non-invasive therapies can save lives and give trust.
– The “Immucura Vibe” is a supportive work environment for personal growth, built on respect, kindness, compassion, and expertise.
– Patients receive loving care and support to live life to the fullest.
Who We Are
Immucura was born with the intent to offer non-invasive therapies to cancer patients all over the world. Since then, the multinational and multidisciplinary team of highly skilled health professionals hasn’t stopped growing. As more and more patients are looking for advanced and natural therapy options, Immucura keeps expanding their services reaching a global market and always going the extra mile, even traveling to the patients’ homes when needed.
What makes us unique
- Dendritic cell production in state-of-the-art laboratories
- 360° Health Evaluation
- Custom medicinal and dietary package for six months
- Six months of individual coverage during and after treatment
- World-class Team of renowned Medical Experts